Africa needs sustainable solutions for mpox vaccine access

Africa requires an estimated ten million doses of mpox vaccine to address a public health emergency, particularly in the Democratic Republic of the Congo, which has reported over 27,000 suspected cases and 1,300 deaths this year. While the US and Europe have pledged donations, concerns remain about vaccine efficacy against new strains and equitable access for low-income countries, highlighting ongoing global health disparities.